Effects of Lansoprazole on Bone Turnover Markers
Launched by ATATURK UNIVERSITY · Mar 23, 2021
Trial Information
Current as of August 25, 2025
Completed
Keywords
ClinConnect Summary
This study is planned to be conducted with children who are diagnosed with gastroesophageal reflux or gastroesophageal reflux disease aged 2-18 years and healthy volunteers. The diagnosis of gastroesophageal reflux will be made in accordance with the guidelines of North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). Written and verbal consent will be obtained from patients/healthy volunteers and/or parents who want to participate in the study. Serum calcium, magne...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Patients diagnosed with gastroesophageal reflux or gastroesophageal reflux disease aged 16 to18 years.
- Exclusion Criteria:
- • Patients with a malabsorptive disease.
- • Patients with any chronic disease.
- • Patients who use any medication that may affect calcium and bone metabolism.
- • Patients who used proton pumps inhibitor within the last 3 months.
- • Patients who do not use lansoprazole in the study group.
- • Patients whose blood and urine samples are not taken in the eighth week of treatment.
About Ataturk University
Atatürk University, located in Erzurum, Turkey, is a prominent academic institution dedicated to advancing research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative medical research aimed at improving patient outcomes and contributing to the global body of health knowledge. Committed to ethical standards and rigorous scientific methodologies, Atatürk University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of its clinical trials, ultimately enhancing the quality of care and driving advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erzurum, , Turkey
Patients applied
Trial Officials
Ali Islek, MD
Principal Investigator
Ataturk University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials